Biodexa Pharmaceuticals Plc (BDRX)
CIK 1643918 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Biodexa Pharmaceuticals Plc.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 11, 2026 | 424B3 | 0001214659-26-011632 |
| Sep 11, 2026 | 424B3 | 0001214659-26-011633 |
| Sep 11, 2026 | 424B3 | 0001214659-26-011636 |
| Sep 11, 2026 | 6-K | 0001214659-26-011630 |
| Sep 11, 2026 | 424B3 | 0001214659-26-011635 |
| Sep 11, 2026 | 424B3 | 0001214659-26-011634 |
| Sep 11, 2026 | 424B3 | 0001214659-26-011637 |
| Sep 11, 2026 | 424B3 | 0001214659-26-011631 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001172661-26-003555 |
| Aug 5, 2026 | 424B3 | 0001214659-26-009578 |
| Aug 5, 2026 | 424B3 | 0001214659-26-009577 |
| Aug 5, 2026 | 424B3 | 0001214659-26-009579 |
| Aug 5, 2026 | 424B3 | 0001214659-26-009576 |
| Aug 5, 2026 | 424B3 | 0001214659-26-009580 |
| Aug 5, 2026 | 424B3 | 0001214659-26-009575 |
| Aug 4, 2026 | 424B3 | 0001214659-26-009509 |
| Aug 3, 2026 | EFFECT | 9999999995-26-002525 |
| Jul 30, 2026 | F-1/A | 0001214659-26-009176 |
| Jul 29, 2026 | 6-K | 0001214659-26-009162 |
| Jul 15, 2026 | F-1 | 0001214659-26-008591 |
| Jul 9, 2026 | 6-K | 0001214659-26-008398 |
| Jul 1, 2026 | 6-K/A | 0001214659-26-007967 |
| Jul 1, 2026 | 424B3 | 0001214659-26-008064 |
| Jul 1, 2026 | 424B3 | 0001214659-26-008065 |
| Jul 1, 2026 | 424B3 | 0001214659-26-008062 |